AGENDA
(Oncology - June 2022)
TUESDAY, JUNE 28, 2022
All Times are EST Time Zone
8:30am // REGISTRATION AND BREAKFAST
9:00am // OPENING REMARKS - Angus McQuilken, Industry Relationship Executive - Life Sciences, McDermott Will & Emery. Bill Werkmeister, Partner, MedInvest Conferences
9:10am // KEYNOTE TALK - Dr. Keith Flaherty, Co-Founder of Loxo Oncology | Director of Clinical Research at the Massachusetts General Hospital. Topic: Precision Oncology.
9:40am // Corporate Presentation - Apricity Health
10:00am // Corporate Presentation - Genomic Expression
10:20am // Corporate Presentation - Sanavia Oncology
10:40am // Corporate Presentation - Impact Therapeutics
11:00am // Corporate Presentation - NKore Biotherapeutics
11:20am // Corporate Presentation - Siva Therapeutics
11:40pm // Corporate Presentation - Pacylex Pharmaceuticals
12:00pm // Corporate Presentation - Aravive
12:20pm // TALK - Kunal Bhatia, Director Healthcare Banking at Cowen and Bill Kadel, Vice President Equity Capital Markets at Cowen. Topic: Biotechnology Capital Markets Update.
12:50pm // LUNCH - Workshop
1:00pm - 2:30pm // CEO WORKSHOP - Achieving Commercial Success with the NIH as a Strategic Partner. Curators: Dr. Michael Salgaller, Director of Tech Transfer, NCI | Supervisor, Invention Development and Marketing Unit (IDMU); Steve Ferguson, Deputy Director, Licensing and Entrepreneurship, National Institutes of Health
2:10pm // Corporate Presentation - BAKX Therapeutics
2:30pm // Corporate Presentation - Oncoxome
2:50pm // Corporate Presentation - NexPlasmaGen
3:10pm // Corporate Presentation - Concarlo Therapeutics
3:30pm // Corporate Presentation - ExoProTher Medical
3:50pm // Corporate Presentation - Kintara Therapeutics
4:10pm // Corporate Presentation - SciTech Development
4:30pm // Corporate Presentation - SmartScan
4:50pm // Corporate Presentation - TRIO Pharmaceuticals
5:10pm // PANEL DISCUSSION: Cellular Therapy. Dr. Phil Friedlander, Professor, Mt. Sinai |Chief Investigator, Iovance; Dr. Alfred Slanetz, CEO, Geneius | Board, NFCR | Former CEO, Bluebird Bio
5:40pm // CLOSING REMARKS
5:50pm // DINNER RECEIPTION
WEDNESDAY, JUNE 29, 2022
All Times are EST Time Zone
8:30am // REGISTRATION AND BREAKFAST
9:00am // OPENING REMARKS
9:10am // KEYNOTE TALK - Dennis Purcell, Founder Aisling Capital. Topic: What's Next for Biotech
9:40am // Corporate Presentation - Stellarray
10:00am // Corporate Presentation - 20/20 Gene Systems
10:20am // Corporate Presentation - Lantern Pharma
10:40am // Corporate Presentation - CytImmune Sciences
11:00am // Corporate Presentation - SmartBreast
11:20am // Corporate Presentation - Rapa Therapeutics
11:40am // Corporate Presentation - SynDevRx
12:00pm // Corporate Presentation - Canget BioTekpharma
12:20pm // TALK - Dr. Niels Emmerich, Global Head of Search and Evaluation, Abbvie. Topic: Abbvie Oncology Pipeline
12:50pm // LUNCH - Workshop
1:00pm - 2:30pm // CEO WORKSHOP - From Horrors to Triumphs - Startup and Growth Fundraising. Curator: Dr. Michael Weickert, CEO of Pacylex Pharmaceuticals | CEO of Fe Pharmaceuticals | 30 Years of Drug and Med Device Development
2:30pm // Corporate Presentation - Revere Pharmaceuticals
2:50pm // Corporate Presentation - Rampart Health
3:10pm // Corporate Presentation - Early Detection
3:30pm // Corporate Presentation - SIWA Therapeutics
3:50pm // Corporate Presentation - Amplified Sciences
4:10pm // Corporate Presentation - KAHR Bio
4:30pm // Corporate Presentation - Geneius Biotechnology
4:50pm // TALK - Dr. Brian Lelyand-Jones, CMO NFCR | Former Director of McGill and Emory Cancer Centers. Topic: The Future of Cancer Care: patient-centric, multi-omic, multi-modality therapy, digital, implantables.
5:20pm // CLOSING TALK - Todd Kornfeld, Partner, McDermott Will & Emery. Topic: The State of Capital Markets for Life Sciences Startups and Alternatives to Consider.
5:50pm // CLOSING REMARKS
6:00pm // COCKTAIL RECEPTION